Cellectis (NASDAQ:CLLS) Stock, Quote.Headers.trade-ideas

Cellectis

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

Earnings

News

Penny Stocks

Upgrades

Markets

Analyst Ratings

CLLS

Cellectis S.A. (NASDAQ: CLLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

Cellectis Upgraded to Buy: Here&#39;s Why

Small Cap

Intraday Update

Movers

Trading Ideas

ACLX

ACXP

AIRE

ALPN

AUDC

AVNW

AWRE

BHIL

CARS

CFLT

CNTB

CRAI

CROX

DASH

DRIO

EGHT

ERII

FROG

FSLY

HOWL

HYZN

INFA

JAKK

JOBY

LMDX

LMND

LOCL

LSPD

LYFT

MCRB

NARI

NVST

OLIT

OMCL

OMGA

OPEN

OTLK

PBLA

PCOR

PKOH

PLPC

PLTR

POET

PTVE

PYPL

QCOM

QNST

RCKY

RELY

ROKU

RVLV

SABR

SBGI

SEDG

SGMO

SHOP

STAA

TENB

THTX

VIRI

XRAY

Gainers


	OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.


Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Pre-Market Outlook

ALBT

SIEN

Gainers

LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently announced the receipt of the Nasdaq delisting determination.

Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

Cellectis S.A. - American Depositary Shares

Cellectis SA

The&nbsp;Committee for Medicinal Products for Human Use (CHMP)&nbsp;of the European Medicines Agency based its positive opinion on results from the MANDARA Phase III trial published in&nbsp;The New England Journal of Medicine, which compared the efficacy and safety of&nbsp;Fasenra&nbsp;to the only approved EGPA treatment, mepolizumab, in patients with relapsing or refractory EGPA.
MANDARA was the first head-to-head non-inferiority trial of biologics in patients with EGPA. Patients were randomized to receive either a single 30 mg subcutaneous injection of&nbsp;Fasenra, or three separate 100 mg subcutaneous injections of mepolizumab every four weeks.

Biotech

Large Cap

Health Care

General

AstraZeneca's Fasenra (Benralizumab) Has Been Recommended For Approval In The European Union As An Add-on Treatment For Adult Patients With Relapsing Or Refractory Eosinophilic Granulomatosis With Polyangiitis

SpaceX CEO Elon Musk said on Monday that there are <a href="https://www.benzinga.com/news/24/09/40967983/spacex-pushes-ahead-with-fifth-starship-test-flight-preparation-despite-no-faa-launch-approvals-in-s">multiple regulatory hurdles</a> to launching a rocket, including getting clearance from the U.S. Fish and Wildlife Service.
What Happened: &#8220;We need multiple Fish licenses to launch a rocket (actually)!,&#8221; Musk wrote on social media platform X, referring to clearance from the United States Fish and Wildlife Service required ahead of space missions confirming that the operations will not impact surrounding wildlife.
The CEO was responding to a snippet of his interview with Lex Fridman from November 2023 where he said, &#8220;Currently, the limiting factor for SpaceX, for Starship launch, is regulatory approval.&#8221;
&#8220;I don&#8217;t think the public is quite aware of the madness that goes on,&#8221; Musk then said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need multiple Fish licenses to launch a rocket (actually)! <a href="https://t.co/K9zj0EqyTZ">https://t.co/K9zj0EqyTZ</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1838089797224497250?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Earlier this month, SpaceX said in a blog post that the delay in getting regulatory approvals for the fifth test flight of its ambitious Starship, despite the launch vehicle being ready, is because the Federal Aviation Administration is consulting with the U.S. Fish and Wildlife on the impact of the proposed flight on surrounding wildlife, among other reasons. 
On Sunday, Musk also raised concerns about the Starship program getting &#8220;smothered&#8221; by government bureaucracy. The bureaucracy is rising and the regulatory red tape is affecting all large projects in America, the CEO said. 
The regulations, Musk previously said, <a href="https://www.benzinga.com/news/24/09/40812203/elon-musk-warns-spacexs-efforts-to-make-life-multiplanetary-would-be-effectively-illegal-without-maj">will intensify </a>if Kamala Harris is elected President in the upcoming elections. While Republican Donald Trump has expressed willingness to initiate a government efficiency commission aimed at reducing regulations, the red tape would only rise under a Democratic party administration, Musk opined.
Why It Matters: Musk on Sunday also said that SpaceX intends to launch about five uncrewed Starships to Mars in two years, elaborating on his timeline from earlier this month.
If the five uncrewed missions land safely, crewed missions will be&nbsp;<a href="https://www.benzinga.com/news/24/09/40972893/trumps-mars-landing-promise-gets-slammed-by-peter-schiff-even-as-elon-musk-says-spacex-plans-5-launc" target="_blank" rel="noreferrer noopener">possible in four years</a>, Musk said. However, in case of challenges, the crewed missions will be postponed another two years, he added, pegging crewed Starship missions to Mars for as early as 2028 and latest by 2030.
However, the Starship has undergone only four test flights to date, and Musk has previously made tall claims about the Starship&#8217;s readiness. Musk aims to take humans to Earth&#8217;s orbit, the Moon, and Mars with the spacecraft. 
However, Musk&#8217;s SpaceX has been increasing its launch frequency with its Falcon launch vehicles alone. Earlier this month, the company launched its <a href="https://www.benzinga.com/news/24/09/40916098/elon-musks-spacex-launches-90th-mission-in-2024-with-over-a-third-of-launch-target-still-to-go">90th mission for the year</a> with its Falcon 9 workhorse accounting for a majority of the launches. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="ttps://www.benzinga.com/news/24/09/40973892/unifor-members-at-gms-cami-assembly-and-battery-assemble-plants-secure-new-contract-with-pay-increas">Unifor Members At GM&#8217;s CAMI Assembly And Battery Assemble Plants Secure New Contract With Pay Increases</a></li>
</ul>
Image Via Shutterstock

SPACE

Tech

Elon Musk Shares It Takes 'Multiple Fish Licenses' To Launch A Rocket: 'I Don't Think The Public Is Quite Aware Of The Madness That Goes On,' Says SpaceX CEO

<a href="https://americanbatterytechnology.com/">&nbsp;American Battery Technology Company</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, has been <a href="https://www.energy.gov/mesc/bipartisan-infrastructure-law-battery-materials-processing-and-battery-manufacturing-recycling">selected for a highly competitive grant for $150 million</a> dollars of federal investment&nbsp;by the U.S. Department of Energy to be applied towards the construction of a new lithium-ion battery recycling facility.
&nbsp;
This facility will be the company's second commercial-scale lithium-ion battery recycling facility and is designed to process approximately 100,000 tonnes of battery materials per year from its battery manufacturer, automotive OEM, and community partners.
"We are extremely honored to be selected for this government investment to further expand our domestic battery recycling operations, and after having gone through nearly one-year of technical and economic evaluation, we appreciate the level of diligence that the government employed in making this decision," stated ABTC CEO Ryan Melsert. "We are greatly appreciative of the confidence and support we have received from our partners throughout this process and are energized to move forward with our feedstock supply, product offtake, and strategic stakeholders in this critical expansion of our domestic capabilities."
True to the company's strategic model to engage a diverse portfolio of partners and stakeholders to bring advanced battery technologies online and establish a commercial battery metals supply chain for North America, this project will leverage multiple partners including feedstock supplier and critical mineral product offtaker BASF, global engineering firm Siemens, the Clemson University International Center for Automotive Research (CU-ICAR), the Argonne National Laboratory (ANL) ReCell Center, the Argonne National Laboratory Sustainable Transportation Education &amp; Partnerships (STEP) department, and the South Carolina Electric Transportation Network (SCETNetwork). &nbsp;
ABTC constructed and commissioned its first lithium-ion battery recycling facility near Reno, Nevada in Fall 2023, which implements its internally-developed processes for the strategic de-manufacturing and targeted chemical extraction of battery materials in order to manufacture battery grade products at competitive costs and with low environmental footprint.&nbsp; These processes are fundamentally different than conventional methods of battery recycling, which generally utilize either high temperature smelting or non-strategic shredding systems.
Through this new facility construction project, ABTC will employ a proactive, community-driven engagement model to build an energy equity, sustainable circular manufacturing ecosystem that aims to create 1,200 construction jobs and 300 operations jobs. The company will work in direct partnership between communities, educational institutions, industry, government, the National Laboratory system, and the next generation workforce to support equitable and sustainable initiatives that benefit and strengthen in local communities, including in underserved communities that have historically been left behind.
ABTC is partnering with government entities and local educational institutions, such as ANL's STEP department and Clemson University, to create career pathways in battery recycling and establish a talent pipeline for the domestic battery recycling industry.
Bringing first-of-kind technologies to market,&nbsp;ABTC's battery recycling and primary battery metals commercialization efforts support the buildout of a domestically-sourced battery metals circular supply chain.&nbsp; ABTC has been selected for several competitive awards supporting the advancement and commercialization of its first-of-kind technologies for both battery recycling and primary claystone-to-lithium hydroxide manufacturing.&nbsp; &nbsp; U.S. DOE Investments in ABTC Lithium-Ion Battery Recycling&nbsp;
<ul>
<li>October 2021: ABTC was awarded a competitive grant for a <a href="https://americanbatterytechnology.com/projects/usabc-project/">$2 million project</a> from the United States Advanced Battery Consortium (USABC) supported by funding from US DOE to foster the recycling of battery packs and extraction of battery metals, with USABC cost contributions of $500k.</li>
<li>November 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was awarded for a competitive grant for a $20 million project from the U.S. DOE to scale</a>, optimize, and commercialize three next generation technologies to even further enhance the performance of its recycling operations, with a federal contribution of $10 million.</li>
<li>March 2024:<a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-20-million-tax-credit-through-competitive-us-doe-process-to-advance-its-critical-minerals-battery-recycling-facility/"> ABTC awarded qualifying advanced energy project tax credits (48C) for $20 million</a> to be applied towards capital expenditures of its first battery recycling facility near Reno, Nevada.</li>
<li>March 2024: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-additional-40-million-competitive-tax-credit-to-accelerate-construction-of-next-battery-recycling-facility/">ABTC awarded qualifying advanced energy project tax credits (48C) for $40 million</a> to be applied towards capital expenditures of its second battery recycling facility.</li>
<li>TBD 2025: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was selected for this competitive grant for a $150 million project from the U.S. DOE to construct a second battery recycling facility</a>.</li>
</ul>
U.S. DOE Investments in ABTC Lithium Hydroxide (LiOH) from Claystone Manufacturing&nbsp;
<ul>
<li>October 2021: <a href="https://www.energy.gov/eere/ammto/advanced-manufacturing-office-fy20-critical-materials-foa-selections">ABTC was awarded a competitive grant supporting a $4.5 million project</a> from the U.S. DOE for the demonstration of its battery-grade lithium hydroxide production from Nevada claystone resources, with federal contributions of $2.27 million.</li>
<li>October 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-for-57m-grant-from-us-doe-for-construction-of-commercial-scale-lithium-hydroxide-refinery/">ABTC was awarded a competitive grant supporting a $115 million project</a> from the U.S. DOE to construct a commercial-scale lithium hydroxide refinery, with a federal contribution of $57.7 million.</li>
</ul>
These battery recycling technologies were developed in-house by the ABTC R&amp;D, project management, and engineering team members, many of whom were previously members of the founding Tesla Gigafactory design and engineering teams. &nbsp;ABTC intends to utilize these significant experiences in collaboration with project partners to scale processes and bring first-of-kind commercial-scale facilities online and leveraging this expertise to de-risk ABTC's commercialization of this second battery recycling facility.
As ABTC has now completed the technical and economic evaluations and been selected for this competitive grant award, it will next enter the grant award contracting phase of this process with an expected project kickoff in 2025.

Government

Regulations

ABAT

American Battery Technology Secures $150M US DOE Grant, Expanding Battery Recycling Facility

Management

Owens & Minor Has Appointed Jonathan Leon As Executive Vice President And Chief Financial Officer, Effective Immediately

Lifezone Metals Limited's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZM#NYSE">LZM</a>) Chief Executive Officer, Chris Showalter, is pleased to announce that Lifezone, in partnership with BHP, has formally commenced the project financing process for the Kabanga Nickel Project in Tanzania. In conjunction, Lifezone has received a Letter of Interest from the U.S. International Development Finance Corporation (DFC) that expressed DFC's interest in considering the Project for loans as part of the Project's financing package.
Tanzanian Minister of Minerals, Hon. Anthony Mavunde, welcomed the news, saying: "The Kabanga Nickel Project is a model example of the Government of Tanzania's commitment to fostering sustainable development and economic growth for the benefit of Tanzania and Tanzanians. We are delighted with the announcement that DFC has signed a Letter of Interest for project finance of Kabanga. Building on the 2023 visit to Tanzania by Vice President Harris, DFC's action shows that Tanzania and the United States continue to develop a strong economic partnership founded on a shared vision for sustainable development and we are looking forward to further developing our relationship to pursue our common goals. This project will not only boost our economy regionally and nationally, but also position Tanzania as a leading international player in the global nickel market, contributing significantly to the global energy transition."
Mr. Showalter also commented: "The initiation of the project financing process with Societe Generale is a crucial next step in securing the funding required for Kabanga, and is yet another indicator of the strategic importance of the Project to our global partners. With DFC's interest in supporting Kabanga, the U.S. government clearly recognizes the critical role that sustainable mineral development in Africa plays in the global energy transition. Today's announcement reinforces this vision and again highlights the strong relationship between the United States and Tanzania."
Scott Nathan, Chief Executive Officer of DFC added: "DFC is helping to advance the global energy transition through projects that drive sustainable development and economic growth. The Kabanga Nickel Project represents a significant opportunity to advance responsible mineral development in Tanzania, diversifying critical supply chains and fostering economic resilience in the region."
The DFC loan application would initiate a comprehensive review process; this follows <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.lifezonemetals.com%2Fnews%2Fpress-releases%2Fnews-details%2F2024%2FLifezone-Metals-Initiates-Process-for-Risk-Insurance-with-U.S.-International-Development-Finance-Corporation-for-the-Kabanga-Nickel-Project-in-Tanzania%2Fdefault.aspx&amp;esheet=54125613&amp;newsitemid=20240923733638&amp;lan=en-US&amp;anchor=Lifezone%26%238217%3Bs+August+27%2C+2024+announcement&amp;index=1&amp;md5=f757042432b47c95de66350df5fb940b">Lifezone's August 27, 2024 announcement</a> that DFC would be evaluating political risk insurance coverage for future investments in Kabanga.
Kabanga is one of the world's largest and highest-grade undeveloped nickel sulfide deposits. By utilizing Lifezone's Hydromet technology, the project is expected to significantly reduce emissions compared to traditional smelting methods.
Kabanga is supported by the Partnership of Global Infrastructure and Investment (PGI), which is a values-driven, high-impact, and transparent infrastructure partnership that was created to meet the enormous infrastructure needs of low- and middle-income countries and to support the United States' and its allies' economic and national security interests. Kabanga is also recognized as a project within the Minerals Security Partnership, a collaboration of 14 countries and the EU to catalyze public and private investment in responsible critical minerals supply chains globally.
DFC is America's development finance institution. It partners with the private sector to finance solutions to the most critical challenges facing the developing world today across sectors including energy, infrastructure, healthcare, agriculture, and financial services. DFC investments adhere to high standards and respect the environment, human rights, and worker rights.
Societe Generale appointed as lead financial advisor to Kabanga Nickel Limited
Societe Generale has been appointed as the lead financial advisor to Kabanga Nickel Limited, a subsidiary of Lifezone that is managed by Lifezone and in which BHP has a 17% interest.
Lenaig Trenaux, Global Head of Batteries, Mining and Industries, Societe Generale, commented: "Societe Generale supports its clients in the energy transition, through dedicated solutions, and a commitment to contribute to sustainable finance. We are very pleased to be working jointly with Lifezone Metals and BHP to deliver the Kabanga Nickel Project, aiming to foster development in Tanzania and feed the energy transition with a large volume of low carbon critical mineral."
Societe Generale brings world-leading expertise in large-scale debt financing for mining projects globally. In cooperation with BHP, Lifezone and Societe Generale will look to optimize Kabanga's capital structure through a combination of multi-source project-level debt and equity.

Lifezone Metals and BHP Begin Project Financing for Tanzania's Kabanga Nickel, Supported by US DFC

Benchmark analyst Cody Acree reiterates Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Hold.

Reiteration

INTC

Benchmark Reiterates Hold on Intel

Needham analyst Mike Cikos reiterates Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and maintains $28 price target.

Price Target

Needham Reiterates Buy on Confluent, Maintains $28 Price Target

Iris Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) (together with its subsidiaries, "IREN") today provided a business update. &nbsp;
"We are pleased to announce that we've reached our 20 EH/s milestone ahead of schedule. This achievement reflects the hard work of our global team. Thank you for your dedication and efforts in making this happen," said Daniel Roberts, Co-Founder and Co-CEO of IREN. "We look forward to continuing this momentum as we expand to over 30 EH/s in the next three months."
IREN achieves 20 EH/s milestone
IREN has increased its installed capacity to 20 EH/s (16 J/TH efficiency).
Through optimization of its existing data center infrastructure, IREN now expects to increase its installed capacity to 21 EH/s in the coming days.
On track for 31 EH/s in 4Q 2024
Childress Phase 3 (150MW) construction is well underway, with approximately 430 people mobilized to site.
As part of the expansion from 21 EH/s to 31 EH/s, previously purchased Bitmain S21 XP miners (13.5 J/TH) are scheduled for shipping over the next 2 months.
Based on 31 EH/s (15 J/TH efficiency):
<ul>
<li>$20k electricity cost per Bitcoin mined</li>
<li>$30k all-in cash cost per Bitcoin mined</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

IREN

Iris Energy Boosts Capacity to 20 EH/s, 31 EH/s Expected by End of 2024

TD Cowen analyst Oliver Chen downgrades Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Buy to Hold and announces $395 price target.

Downgrades

ULTA

TD Cowen Downgrades Ulta Beauty to Hold, Announces $395 Price Target

On September 20, 2024 the Board of Directors declared a quarterly cash dividend of 25.0 cents per share on the Company's common stock. The Board of Directors also approved a one-time special dividend of $2.50 per share.&nbsp;

Dividends

Ennis, Inc Declares $0.25 Quarterly Dividend, Approves Special $2.50 Payout

Strategic Synergies
The integration of Swifty is expected to bring several operational advantages and new revenue opportunities for Signing Day Sports:
<ul>
<li>Cost Efficiency: Swifty's in-house engineering team is expected to reduce Signing Day Sports' operating costs by over 50%, enabling the company to reinvest those savings into growth initiatives. It is also expected to increase the speed at which Signing Day Sports can roll out new products and technological enhancements to its current offering and optimize monetization of the product and user base.</li>
<li>Revenue Growth in SaaS: At their core, both Signing Day Sports and Swifty are SaaS model businesses. Swifty's scalability, technological resources, and technology initiatives are expected to bolster the growth of Signing Day Sports' app user base, enhance user retention and provide additional opportunities to monetize renewing subscribers with additional revenue streams.</li>
<li>New Revenue Streams: Swifty is expected to further expand Signing Day Sports' current product offering while also broadening the Company's exposure to new sports and athletes outside the U.S. Signing Day Sports has accumulated more than 10,000 registered users, which it plans to increase at an accelerated rate in the fourth quarter of 2024 and 2025. The Company's focus is to develop new strategic revenue streams, and improve revenue metrics per user, with the same aim of fully monetizing this growing user base.</li>
<li>New Market Exposure: Since its beginning as a football student-athlete recruitment platform provider, Signing Day Sports has expanded its platform to support baseball, softball, and men's and women's soccer. Swifty is expected to bring exposure to new markets in Europe, Africa and the Middle East, as well as exposure to emerging sports without established recruitment models. The Company anticipates that early adopters in these emerging sports markets are a significant market and plans to broaden its platform to capitalize on these prospective revenue streams.</li>
<li>Enhanced User Engagement: Swifty's team is expected to introduce exciting new features to Signing Day Sports, including gamification elements such as live scoreboards, top competitor leaderboards, fantasy leagues and real-time performance tracking, which are designed to boost engagement, organic user acquisition and user retention.</li>
</ul>

Signing Day Sports Provided An Update Regarding Its Financial Position And Its Plans To Acquire Dear Cashmere, Doing Business As Swifty Global, Highlighting The Strategic And Financial Synergies That Are Expected To Drive Accelerated Growth And Operational Efficiency For Both Companies

XOMA

ZVRA

XOMA Royalty Says Zevra Therapeutics Received FDA Approval For MIPLYFFA; Says It Is Entitled To Receive Mid-single Digit Royalty On MIPLYFFA Sales And Up To $52.6M In Milestones

Earnings Misses

Ennis Q2 2024 GAAP EPS $0.40 Misses $0.42 Estimate, Sales $99.038M Miss $104.580M Estimate

HC Wainwright &amp; Co. analyst Robert Burns reiterates Repare Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) with a Buy and maintains $10 price target.

RPTX

HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target

The cryptocurrency market has seen a significant surge in pre-market activity after Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reached a new high of $63,500.
What Happened: Following Bitcoin&#8217;s 0.4% increase, several Bitcoin ETFs experienced a surge in pre-market activity on Monday. As per <a href="https://pro.benzinga.com">Benzinga Pro</a>, Grayscale Bitcoin Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#NYSE">GBTC</a>) rose by 1.46%, Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>) by 1.31%, and ProShares Bitcoin Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITO#NYSE">BITO</a>) by 1.21%. Other ETFs, including Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>) and ARK 21Shares Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>), also witnessed minor increases of 0.99% and 0.77%, respectively. 
Reuters reported that Chris Weston, head of research at Pepperstone, attributed the surge to the &#8220;goldilocks macro backdrop,&#8221; which he believes is the primary driver of the current upward momentum. He also noted that Bitcoin&#8217;s rallies tend to be powerful, sparking significant FOMO (fear of missing out) among crypto investors.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40968244/trumps-new-crypto-ventures-legal-counsel-accused-of-attempting-to-seize-control-of-rival-f?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s New Crypto Venture&#8217;s Legal Counsel Accused Of Attempting To Seize Control Of Rival Firm</a>
Why It Matters: This surge in Bitcoin ETFs comes on the heels of a recent report by 10x Research, which suggested that <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40955750/bitcoins-correction-ends-but-it-has-to-break-this-target-to-surge-to-70k-10x-research">Bitcoin&#8217;s correction phase </a>may have ended. The report indicated a potential surge towards the $70,000 mark, with trading signals showing a favorable buying opportunity for Bitcoin and Ethereum.
Earlier in September, a viral story <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40946963/bitcoin-worth-63-000-pulled-in-33-pack-of-trading-cards-at-gamestop-mind-boggling-story-go">about a GameStop customer</a> who turned a $33 trading card pack into a full Bitcoin worth over $60,000 also highlighted the growing influence of cryptocurrency in mainstream markets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40972902/kamala-harris-finally-mentions-crypto-and-that-too-on-wall-street-promises-to-encourage-in?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Kamala Harris Finally Mentions Crypto And That Too On Wall Street: Promises To Encourage &#8216;Innovative Technologies&#8217; Like Digital Assets</a></li>
</ul>
Photo courtesy: Unsplash
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

BITO

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

Bitcoin ETF Surge In Pre-Market As King Crypto Hits $63,500

Needham analyst Bernie McTernan reiterates DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) with a Buy and maintains $60 price target.

DKNG

Needham Reiterates Buy on DraftKings, Maintains $60 Price Target

TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) inked a deal to supply Air France-KLM with up to 1.5 million tons of sustainable aviation fuel (SAF) over the next 10 years, through 2035.
This is one of Air France-KLM&#8217;s largest SAF agreements. This contract builds on a 2022 memorandum of understanding (MoU) for the supply of 800,000 tons of SAF.
By revisiting the agreement, both groups are reinforcing their commitment to reducing the environmental impact of air transport and lowering CO2 emissions as quickly as possible.
Patrick Pouyanné, Chairman and CEO of TotalEnergies, said, &#8220;SAF contributes both to the energy transition of our customers in the aviation sector and to the industrial transition of our refineries. It therefore represents a real &#8216;win-win&#8217; for the future of industry and aviation.&#8221;
&#8220;Securing the volumes of more sustainable aviation fuel needed to decarbonize our activity is a major challenge. This agreement with TotalEnergies is a further step in this direction, and a testament to our long-standing support for the development of SAF production in France and Europe,&#8221; said&nbsp;Benjamin Smith, Chief Executive Officer of Air France-KLM Group.
Notably, TotalEnergies has invested 340 million euros to convert its refinery into a biorefinery. In 2024, the company invested an additional 70 million euros to process up to 100% of waste from the circular economy, with plans to produce sustainable aviation fuel (SAF) by 2025.
Last week, TotalEnergies extended its sales and purchase agreement (SPA) with CNOOC <a target="_blank" href="https://www.benzinga.com//node/40934542" rel="noreferrer noopener">by an additional five years</a>.
Also, the company inked a 10-year deal with BOTAŞ to supply 1.1 million tons of <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40919924/totalenergies-expands-in-turkey-with-long-term-lng-agreement" rel="noreferrer noopener">LNG annually starting in 2027.</a>
Apart from this, this month, the company formed a 50/50 joint venture with Adani Green for a 1,150 MW solar project in Gujarat, India. TotalEnergies will invest $444 million,&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40681721/totalenergies-invests-in-indian-solar-projects-forms-jv-with-adani-green-energy" rel="noreferrer noopener">boosting its renewable energy strategy</a>.
Investors can gain exposure to the stock via&nbsp;Advisor Managed Portfolios Miller Value Partners Appreciation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MVPA#NYSE">MVPA</a>) and&nbsp;Octane All-Cap Value Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCTA#NASDAQ">OCTA</a>).
Price Action: TTE shares closed lower by 0.07% at $69.09 on Friday.

Equities

Contracts

MVPA

OCTA

TotalEnergies And Air France-KLM Double Down On Sustainability: SAF Deal Paves The Way To Carbon-Free Skies

Needham analyst Bernie McTernan initiates coverage on Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Buy rating and announces Price Target of $270.

Initiation

FLUT

Needham Initiates Coverage On Flutter Entertainment with Buy Rating, Announces Price Target of $270

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Buy and maintains $80 price target.

CRBP

HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $80 Price Target

TD Cowen analyst Andrew Charles reiterates McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Hold and maintains $280 price target.

TD Cowen Reiterates Hold on McDonald's, Maintains $280 Price Target

Cellectis SA (CLLS) has released an update. Cellectis SA, a clinical-stage biotech company, has just appointed Dr. Adrian Kilcoyne as the new Chief...

Cellectis Boosts Leadership with New CMO

Yanan Zhu, an analyst from Wells Fargo, maintained the Hold rating on Cellectis SA (CLLS – Research Report). The associated price target is $3.00. ...

Cellectis SA: A Balanced Hold Recommendation Amidst Clinical Updates and Strategic Changes

Analyst Silvan Tuerkcan from JMP Securities reiterated a Buy rating on Cellectis SA (CLLS – Research Report) and keeping the price target at $6.00....

Cellectis SA: A Strong Buy on CAR T Advancements and Robust Financial Outlook

Cellectis Non-GAAP EPS of -$0.22 beats by $0.09, revenue of $9.5M misses by $0.2M

Cellectis SA (CLLS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on August 7. Analyst Jack Allen from R...

Cellectis SA: Strong Buy Rating on Robust Pipeline and Financial Stability

Cellectis SA (CLLS) has released an update. Cellectis SA, a clinical-stage biopharmaceutical company, has published research showcasing its breakth...

Cellectis Reveals Promising Cancer Therapy Breakthrough

Cellectis: Cheap With Promising But Speculative Cancer Therapies

Cellectis S.A.: Cheap With Promising But Speculative Cancer Therapies

Cellectis SA (CLLS) has released an update. Cellectis SA, a leader in gene-editing biotechnology, has announced promising pre-clinical results for ...

Cellectis' Breakthrough in TNBC Therapy

Cibus announces proposed public offering of Class A common stock

ALLO

AZNCF

CBUS

CMVLF

IOVA

Press Releases

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis' UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment

FDA Grants Orphan Drug Designation to Cellectis' CLLS52 (alemtuzumab) For ALL Treatment

Cellectis Provides Financial Results for the Second Quarter 2024

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Atossa Therapeutics

Cabaletta Bio

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Cellectis

Cellectis (CLLS) Forecast

Cellectis (NASDAQ:CLLS) Stock, Quote.Headers.trade-ideas